Compare BNGO & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNGO | COSM |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 12.9M |
| IPO Year | 2018 | 2009 |
| Metric | BNGO | COSM |
|---|---|---|
| Price | $1.09 | $0.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 97.1K | ★ 8.3M |
| Earning Date | 05-13-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.50 | 46.15 |
| EPS | N/A | ★ N/A |
| Revenue | $12,000,735.00 | ★ $65,271,815.00 |
| Revenue This Year | $14.99 | $54.08 |
| Revenue Next Year | $34.73 | $32.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 26.26 | 19.93 |
| 52 Week Low | $1.06 | $0.16 |
| 52 Week High | $5.50 | $1.32 |
| Indicator | BNGO | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 38.81 | 36.37 |
| Support Level | $1.08 | $0.16 |
| Resistance Level | $1.19 | $0.28 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 14.29 | 3.13 |
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.